1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-10-01 Sage Accounts Production Advanced 2025 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 10949700 2024-10-01 2025-09-30 10949700 2025-09-30 10949700 2024-09-30 10949700 2023-10-01 2024-09-30 10949700 2024-09-30 10949700 2023-09-30 10949700 bus:Director1 2024-10-01 2025-09-30 10949700 core:WithinOneYear 2025-09-30 10949700 core:WithinOneYear 2024-09-30 10949700 bus:Micro-entities 2024-10-01 2025-09-30 10949700 bus:AuditExemptWithAccountantsReport 2024-10-01 2025-09-30 10949700 bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 10949700 bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 10949700 bus:FullAccounts 2024-10-01 2025-09-30
COMPANY REGISTRATION NUMBER: 10949700
EC Diagnostics Limited
Filleted Unaudited Financial Statements
30 September 2025
EC Diagnostics Limited
Statement of Financial Position
30 September 2025
2025
2024
£
£
Fixed assets
351
842
----
----
Current assets
197,794
122,691
Creditors: amounts falling due within one year
28,239
20,817
---------
---------
Net current assets
169,555
101,874
---------
---------
Total assets less current liabilities
169,906
102,716
Accruals and deferred income
1,254
2,112
---------
---------
168,652
100,604
---------
---------
Capital and reserves
168,652
100,604
---------
---------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2024: 1 ).
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 28 May 2026 , and are signed on behalf of the board by:
Dr E Cheasty
Director
Company registration number: 10949700
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 161 Putney Bridge Road, London, SW15 2NZ.